To date, our latest management information indicates a wastage rate of around only 1.8% - well below our planning assumption of 5%, which is a precautionary approach for worst case scenarios and in line with global best practice. Some wastage is unavoidable for a variety of reasons based on the characteristics of the vaccine, logistical issues with cold ch...